Common immune‐related risk factors and incident non‐Hodgkin lymphoma: The multiethnic cohort
Open Access
- 14 July 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 125 (6), 1440-1445
- https://doi.org/10.1002/ijc.24456
Abstract
Severe immune dysfunction is an established risk factor of lymphoma, but the role of moderate alterations of immunity is not clear and prospective investigations are needed. We examined several immune‐related disorders and medications in relation to non‐Hodgkin lymphoma (NHL) in the Multiethnic Cohort. Over 215,000 subjects of African American, Caucasian, Japanese American, Latino and Native Hawaiian ancestry aged 45–75 years completed a questionnaire, including information on medical history, in 1993–1996. After exclusions, we performed Cox regression among 193,050 cohort members including 939 incident NHL cases while adjusting for sex, age, ethnicity, education, body mass index and alcohol intake. Self‐reported diabetes was not associated with NHL overall, but was positively associated with risk among Japanese Americans [hazard ratio (HR) = 1.55; 95% confidence interval (CI): 1.10–2.17]. Participants with a history of blood transfusion were at increased risk with HR = 1.39 (95% CI: 1.06–1.84) in men and HR = 1.22 (95% CI: 0.94–1.58) in women, especially for the diffuse large B‐cell lymphoma subtype. History of asthma or other allergies was associated with elevated risk only among Latinos (HR = 1.46; 95% CI: 1.07–2.00) who also showed a significant relation between current use of antihistamines and NHL (HR = 1.80; 95% CI: 1.09–2.97). Use of nonsteroidal anti‐inflammatory drugs was not associated with NHL. Our findings from this large prospective study support a moderate risk for NHL related to blood transfusions, current long‐term antihistamine use and diabetes, but the associations were limited to certain ethnic groups and require further replications. © 2009 UICCKeywords
This publication has 47 references indexed in Scilit:
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypesBlood, 2008
- Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurementsClinical Trials, 2008
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumBlood, 2008
- Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphomaCancer Causes & Control, 2007
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)Blood, 2007
- The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma riskCancer Causes & Control, 2007
- Altered Immunity as a Risk Factor for Non-Hodgkin LymphomaCancer Epidemiology, Biomarkers & Prevention, 2007
- Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphomaCancer Causes & Control, 2005
- Choice of time‐scale in Cox's model analysis of epidemiologic cohort data: a simulation studyStatistics in Medicine, 2004
- A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemiaCancer, 1971